Stay on the Sanofi Drug?
Feb10

Stay on the Sanofi Drug?

The U.S. District court for the district of Delaware awarded injunction to Amgen against Sanofi to remove its drug  from the market when it was found that Sanofi was infringing Amgen’s drug. Sanofi’s drug ‘Praluent’ was said to infringe Amgen’s counterpart of the same drug, ‘Repatha’ as they both used as they both used an inhibitor of the same protien which is called PCSK9. To Amgen’s...

Read More